TERRI STROBEL: Open Payments
NPI 1932328143 · WOODSBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 29 payments from 12 companies in 2025. Trend: 2023 $261 · 2024 $739 · 2025 $650
Food & beverage: $580Education: $70
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $119 |
| Lilly USA, LLC | 5 | $109 |
| GlaxoSmithKline, LLC. | 4 | $88 |
| Novo Nordisk Inc | 4 | $79 |
| Amgen Inc. | 3 | $60 |
| PFIZER INC. | 3 | $55 |
| ABBVIE INC. | 2 | $32 |
| Exact Sciences Corporation | 1 | $24 |
| Lundbeck LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: MOUNJARO, TRELEGY ELLIPTA, Veozah, Ozempic, PREVNAR 20, QULIPTA, KRYSTEXXA, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
